Vice Provost and Dean of Research
Showing 61-80 of 157 Results
-
Kiran Khush, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Khush's clinical research interests include the evaluation of donors and recipients for heart transplantation; mechanisms of adverse outcomes after heart transplantation, including cardiac allograft vasculopathy and antibody-mediated rejection; and development of non-invasive diagnostic approaches for post-transplant monitoring.
-
Mathew Kiang
Assistant Professor of Epidemiology and Population Health (Epidemiology)
BioI am an assistant professor in the Department of Epidemiology and Population Health. My research lies at the intersection of computational epidemiology and social epidemiology. Methodologically, my work revolves around combining disparate data sources in epidemiologically meaningful ways. For example, I work with individual-level, non-health data (e.g., GPS, accelerometer, and other sensor data from smartphones), traditional health data (e.g., survey, health systems, or death certificate data), and third-party data (e.g., cellphone providers or ad-tech data). To do this, I use a variety of methods such as joint Bayesian spatial models, traditional epidemiologic models, dynamical models, microsimulation, and demographic analysis. Substantively, my work focuses on socioeconomic and racial/ethnic inequities, substance use, and child health. For example, recently, my work has examined inequities in COVID-19 vaccine distribution, cause-specific excess mortality, and drug poisonings. Other work has examined the impact of changing vaccination rates on the reemergence of infectious diseases and the prevalence of parental death among children.
-
Madeleine Douglass Kieca
Industrial Contracts Offcr 1, Office of Technology Licensing (OTL)
BioMaddy is an Industrial Contracts Officer in the Office of Technology Licensing at Stanford after practicing as an attorney for over ten years external to the University. Maddy has experience negotiating and drafting contracts as well as interfacing directly with various individual and entity clients. She received her BA in English with an emphasis in Creative Writing from the University of Southern California and her JD from Santa Clara University School of Law. She is admitted to practice law in the State of California.
-
Nuzhet Inci Kilic
Visiting Researcher Student, GR Visiting Researcher
BioI am a PhD student in the Fiber and Polymer Technology Department at KTH Royal Institute of Technology in Stockholm, Sweden. I graduated in Materials Science and Nanotechnology Engineering with a BSc at TOBB University of Economics and Technology (Turkey) and an MSc in Nanotechnology at KTH Royal Institute of Technology (Sweden). I am currently also a visiting student researcher at Stanford University.
My research interests lie at the intersection of nanomaterials, functional bio-based materials, and sustainable electronics. Specifically, I focus on integrating conducting and functional materials with cellulose-based fibers to develop advanced materials for applications such as energy storage, sensors, actuators, and paper-based electronics. My work explores how tailoring the structure and surface chemistry of cellulose can enhance electronic and ionic conductivity, while also investigating scalable fabrication approaches including industrial papermaking and advanced material processing techniques. During my research, I also work on advanced characterization of these materials to better understand their structure-property relationships and improve their performance in emerging electronic and energy technologies. -
Hyunjin Kim
Licensing Manager, Life Sciences, Office of Technology Licensing (OTL)
BioHyunjin is a Licensing Manager at Stanford Office of Technology Licensing. Hyunjin holds a PhD in Biochemistry from the University of Illinois at Chicago. With a strong foundation in life sciences, Hyunjin joined Aspire Capital as a biotech analyst intern where she gained valuable experience in analyzing and assessing biotech companies with clinical stage assets. After the internship, Hyunjin joined the Office of Technology Management at University of Illinois at Chicago where she managed various intellectual properties. At Stanford, Hyunjin is responsible for managing life science portfolios.
-
Juyong Brian Kim
Assistant Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsThe lifetime risk of developing cardiovascular disease (CVD) is determined by the genetic makeup and exposure to modifiable risk factors. The Cardiovascular Link to Environmental ActioN (CLEAN) Lab is interested in understanding how various environmental pollutants (eg. tobacco, e-cigarettes, air pollution and wildfire) interact with genes to affect the transcriptome, epigenome, and eventually disease phenotype of CVD. The current focus is to investigate how different toxic exposures can adversely remodel the vascular wall leading to increased cardiac events. We intersect human genomic discoveries with animal models of disease, in-vitro and in-vivo systems of exposure, single-cell sequencing technologies to solve these questions. Additionally, we collaborate with various members of the Stanford community to develop biomarkers that will aid with detection and prognosis of CVD. We are passionate about the need to reduce the environmental effects on health through strong advocacy and outreach.
(http://kimlab.stanford.edu) -
Peter S. Kim
Virginia and D. K. Ludwig Professor of Biochemistry
Current Research and Scholarly InterestsOur research focuses on developing new strategies for vaccine creation. We also aim to generate vaccines targeting infectious agents that have eluded efforts to date. We integrate experimental approaches with protein language models to guide artificial evolution and enable efficient antibody and protein engineering. Our interdisciplinary approach aims to address critical global health challenges.
-
Seung K. Kim M.D., Ph.D.
KM Mulberry Professor, Professor of Developmental Biology, of Medicine (Endocrinology) and, by courtesy, of Pediatrics (Endocrinology)
Current Research and Scholarly InterestsWe study the development of pancreatic islet cells using molecular, embryologic and genetic methods in several model systems, including mice, pigs, human pancreas, embryonic stem cells, and Drosophila. Our work suggests that critical factors required for islet development are also needed to maintain essential functions of the mature islet. These approaches have informed efforts to generate replacement islets from renewable sources for diabetes.
-
Sun Kim, M.D. M.S.
Associate Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsWe are interested in studying the pathophysiological processes that contribute to glucose intolerance and type 2 diabetes mellitus. My current research focuses on characterizing pancreatic beta-cell function in populations with significant insulin resistance and vulnerability to developing diabetes: individuals with schizophrenia, morbid obesity, and history of gestational diabetes.
-
Yong Yean Kim
Assistant Professor of Pediatrics ( Hematology & Oncology)
BioOur lab is interested in translational science to bring new therapies to clinical trials. In particular, we are interested in pediatric sarcomas which have not had advancement in clinical treatment for decades. Current projects in the lab focus on understanding of the biology of fusion transcription factor PAX3::FOXO1 which is the driver mutation in fusion positive rhabdomyosarcoma. PAX3::FOXO1 is a powerful oncogenic transcription factor which rewires the transcriptional organization to lock the cancer cell in the proliferative state. Since transcription factors including PAX3::FOXO1 are difficult to target using small molecules, we aim to understand how PAX3::FOXO1 is regulated and targeting the regulators of PAX3::FOXO1. By understanding and targeting the regulation of PAX3::FOXO1, we hope to bring new therapies for fusion positive rhabdomyosarcoma. Additionally, these regulatory mechanisms may also be active in other transcription driven cancers such as the EWSR1::FLI1 driven Ewings Sarcoma.
Our lab is also interested in exploring the epigenetic landscape of pediatric solid tumors and trying to understand how dysregulation in the epigenome drives oncogenesis. We utilize various CRISPR mediated genetic techniques to interrogate the regulators of epigenome focusing on the histone lysine demethylases (KDMs). KDMs are an understudied group of epigenetic regulators which can be targeted for therapeutic effect. We explore the role of KDMs in pediatric solid tumors and hope to identify potential targets for drug development.
